Marvel Biosciences Corp. (MRVL.V)
0.18
+0.02
(+9.09%)
CAD |
TSXV |
Apr 02, 16:00
Marvel Biosciences Shareholders Equity (Quarterly) : -3.859M for Jan. 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arch Biopartners, Inc. | -3.599M |
| Aptose Biosciences, Inc. | -37.24M |
| MedMira, Inc. | -24.03M |
| Innovotech, Inc. | 3.597M |
| Entheon Biomedical Corp. | 0.2243M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.3196M |
| Total Liabilities (Quarterly) | 4.178M |
| Debt to Equity Ratio | -0.5986 |
| Current Ratio | 0.0765 |
| Net Debt Paydown Yield | -1.53% |